Bittersweet pills

Wylot, Robert
December 2001
Warsaw Business Journal;12/10/2001, Vol. 7 Issue 50, p1
Examines the implications of the planned European Union (EU) membership of Poland to the pharmaceuticals industry. Merits of the planned EU membership; Expansion of Western European drug makers in the country; Reform of the public health care system.


Related Articles

  • Croatia, pharma and corruption. Jessop, Nathan // Pharmaceutical Technology Europe;Aug2011, Vol. 23 Issue 8, p9 

    The article focuses on the decision of the European Union (UN) to approve Croatia's EU membership application as issues concerning corruption, organised crime and counterfeit pharmaceuticals seem to have been overcome. It states that the pharmaceutical market has grown as a result of the move of...

  • Opening up Europe. O'Donnell, Peter // Applied Clinical Trials;Feb2000, Vol. 9 Issue 2, p22 

    Examines the impact and benefits of the enlargement of European Union (EU) to include former communist countries of Central and Eastern Europe (CEE) to the pharmaceutical industry. Industry's concern over the way EU enlargement is process; Opportunities of the EU enlargement to the industry, as...

  • From regulations to drug delivery... Mulligan, Thomas // Life Science Today;Apr2000, Vol. 1 Issue 2, p1 

    Editorial. Discusses the regulatory requirements imposed by the European Union on the pharmaceutical industry. Articles on process engineering; Development of drug delivery methods; Collaborations between academia and the industry.

  • Eastern European Pharma Sector to Face Mixed Results Following Its Entry Into the EU. Milano, Sean // Chemical Market Reporter;6/23/2003, Vol. 263 Issue 25, p6 

    Reports on the outcomes of the entry of Eastern European manufacturers of pharmaceuticals and related intermediaries into the European Union. Factors affecting the entry of Eastern European pharmaceutical manufacturers; Impact on Western European counterparts; Discussion on the regulations of...

  • The EU's Falsified Medicines Directive and APIs.  // Pharmaceutical Technology Europe;Feb2013, Vol. 25 Issue 2, p50 

    The article presents questions and answers related to the impact of the Falsified Medicines Directive on the production of active pharmaceutical ingredients in the European Union.

  • A sometimes unhealthy coalition. Iheanacho, Ike // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;5/22/2010, Vol. 340 Issue 7756, p1144 

    The author reflects on the coalition between pharmaceutical industry and drug regulators in the European Union (EU).

  • EU pharmacovigilance fees explained by EMA.  // Reactions Weekly;Mar2015, Vol. 1544 Issue 1, p3 

    The article reports that the European Medicines Agency (EMA) has published an explanation of fees payable to the EMA for monitoring the safety of drugs that have been authorised in the EU. It describes types of fees, and fee exemptions.

  • Obstacles and Optimism as Turkey Embarks on EU Accession Talks. Gorvett, Jon // Washington Report on Middle East Affairs;Dec2005, Vol. 24 Issue 9, p38 

    This article reports that for many Turks this year, Ramadan started in a more celebratory mood than usual, as news came that the European Union (EU) accession talks finally had begun--46 years after Turkey first applied. According to a poll conducted, only Hungary had anything like a majority in...

  • Danger! Family Life Ahead. Vassilev, Boyko // Transitions Online;2/10/2014, p9 

    The article reports that Serbia has started its journey toward becoming a member of the European Union (EU) in late January 2014. Fifteen years ago when Serbia fought a war over Kosovo, the most important figures of the current Serbian government were ardent West-bashers but now they think...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics